Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000309054 | SCV000340228 | uncertain significance | not provided | 2018-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079528 | SCV000756320 | likely benign | Succinate-semialdehyde dehydrogenase deficiency | 2025-01-24 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001079528 | SCV001441350 | uncertain significance | Succinate-semialdehyde dehydrogenase deficiency | 2022-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000309054 | SCV001770207 | likely benign | not provided | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003957465 | SCV004774736 | likely benign | ALDH5A1-related disorder | 2022-09-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |